Neal Secrist
Family Medicine · Wichita, KSNPI 1790735728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 31.0% of the total. Reporting peaked in 2021 at $376 and has fallen 70.8% since, to $110 in 2025.
Across 81 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$463
- Lilly USA, LLC$141
- Jazz Pharmaceuticals Inc.$99
- Amgen$78
- Pfizer$76
- AstraZeneca$73
- plus $563 from 19 others
Across 199 payments — averaging $2699.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$497K
- Pfizer$34K
- Kowa Research Institute, Inc.$6K
What the payments were for
- Food & beverage$1,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $463 |
| Lilly USA, LLC | 10 | $141 |
| Jazz Pharmaceuticals Inc. | 1 | $99 |
| Amgen | 5 | $78 |
| Pfizer | 5 | $76 |
| AstraZeneca | 5 | $73 |
| AbbVie | 5 | $70 |
| Johnson & Johnson | 4 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Sanofi Pasteur Inc. | 3 | $47 |
| Astellas Pharma US Inc | 3 | $44 |
| Merck | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Novartis | 2 | $29 |
| Corium, LLC | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Bayer | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,493 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Np ThyroidThyroid,pork | 25 | $1,463 |
| Liothyronine Sodium | 12 | $880 |
| Spironolactone | 11 | $104 |
| Levothyroxine Sodium | 15 | $42 |
| Anastrozole | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.